-+ 0.00%
-+ 0.00%
-+ 0.00%
All Invest Securities keeps Buy on ABL Diagnostics, target price €8.7
Share
Listen to the news
All Invest Securities keeps Buy on ABL Diagnostics, target price €8.7
  • All Invest Securities reiterated a Buy rating on ABL Diagnostics in a Sept. 14, 2026 equity research report.
  • Target price held at EUR 8.7 per share.
  • Report cited strong first-half 2026 revenue growth, improved profitability, confirmed full-year guidance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260914583266) on September 14, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending